Secondly, the magnitude and pace of albuminuria development in STZ-eNOS−/− mice occurring within two to three weeks of diabetes induction18, 31, allows the relatively rapid in vivo screening of compounds for possible anti-albuminuric actions31. The gene discussed is NOS3; the disease is diabetes mellitus.